AeroRx Therapeutics
PrivateLast Round
Series A
Oct 7, 2025
Total Funding Raised
$27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AeroRx Therapeutics is a biotechnology company that develops proprietary, nebulized combination drug therapies for the treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AeroRx Therapeutics Comparables
Compare AeroRx Therapeutics with similar companies based on industry and business-model similarity.
AeroRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2025 | ||||
| Seed | Apr 1, 2024 |
AeroRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexandria Venture Investments | Series A |
| Avalon BioVentures | Series A |
| Correlation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
$21M round completed.
AeroRx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AeroRx Therapeutics's valuation, stock price, and market status.